CIC
OLMA icon

Cornercap Investment Counsel’s Olema Pharmaceuticals OLMA Stock Holding History

Cornercap Investment Counsel’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,330
Closed -$229K – 633
2023
Q2 		$229K Sell
25,330
-25,822
-50% -$156K 0.04% 492
2023
Q1 		$177K Hold
51,152
– – 0.03% 510
2022
Q4 		$125K Hold
51,152
– – 0.02% 528
2022
Q3 		$141K Hold
51,152
– – 0.03% 517
2022
Q2 		$208K Buy
+51,152
New +$162K 0.04% 487

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cornercap Investment Counsel's OLMA Position: Q3 2023 in Review

Cornercap Investment Counsel sold out of Olema Pharmaceuticals (OLMA) in Q3 2023, closing a stake of 25,330 shares — an estimated $229K sold.

Cornercap Investment Counsel first reported a position in OLMA in Q2 2022 and held it in 5 quarters. The position peaked at $229K in Q2 2023. 97 funds tracked by Wall St. Rank hold OLMA as of Q3 2023.

  • Cornercap Investment Counsel reported no remaining Olema Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 25,330 Olema Pharmaceuticals shares in Q3 2023, an estimated $229K.
  • Cornercap Investment Counsel first reported a position in Olema Pharmaceuticals in Q2 2022 and held it in 5 quarters.
  • Cornercap Investment Counsel's Olema Pharmaceuticals position peaked at $229K in Q2 2023.
  • 97 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2023.

Based on Cornercap Investment Counsel's 13F filing for Q3 2023, filed 13 Nov 2023.